IFNG and lung carcinoma: Li, (79) used human peripheral blood to confirm that IL-33 can promote the secretion of IFN-γ and GzmB in PBMCs in vitro, and further confirmed that IL-33 can enhance the cytotoxic effect of PBMCs on tumor cells and increase the activity of PMBCs to eliminate the lung cancer cells.